As part of efforts to reduce 30-day unplanned readmissions, Cleveland Clinic has instituted five-day follow-up for all cancer patients discharged after hospitalization.Read More
The inability to return to work, frequent physician visits, loss of insurance and need for multiple medications and treatments specific for cGVHD were associated with financial burden.
This multicenter study shows that even with the relatively favorable outcomes of non-transplanted patients with mantle cell lymphoma in the modern era, the use of consolidation autologous stem cell transplant appears to further-improve progression-free and overall survival.
A review of trials examining several new approaches, including agents that inhibit various points in the Janus kinase and other pathways that underlie the condition, as well as potential concomitant agents that can help minimize anemia and/or thrombocytopenia to enable more effective dosing of primary treatments.
Cleveland Clinic researchers recently found higher costs and death rates among cancer patients who go to the emergency department due to venous thromboembolism. They recommend prevention and/or early detection.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic physicians created a new system that incorporates individual patient genomic and clinical data and uses a machine-learning algorithm to better predict an individual patient’s outcome.
A new imaging modality may offer a wealth of prognostic information on tumor behavior and differentiation of cancer subtypes.
Cleveland Clinic oncologists conducted a new meta-analysis of breast cancer lumpectomy patients to determine the best margins to prevent additional surgery and optimize long-term survival.
Here’s a look at how our team treated a 71-year-old man with nine months of progressive swallowing difficulties associated with epigastric and chest discomfort.
Due to improved industrial hygiene measures, acute beryllium disease has essentially disappeared, but chronic beryllium disease (CBD) continues to affect workers in industries where beryllium is manufactured and processed.